Panacea Biotec Of India To Buy Stake In PharmAthene Of U.S.
This article was originally published in PharmAsia News
Executive Summary
India's Panacea Biotec plans to buy a large stake in PharmAthene, a U.S. biodefense company that makes products to counter biological and chemical threats. Panacea intends to buy 14.5 percent of the U.S. firm for $13.1 million through its Kelisia Holdings, a wholly owned subsidiary. The deal also gives Panacea the option of buying enough shares to give it practically a 20 percent stake in the American firm. (Click here for more
You may also be interested in...
Cosmetic And Personal Care Trademark Review: 16 April
Personal care and cosmetic product trademark filings compiled from the Official Gazette of the US Patent and Trademark Office, Class 3.
Health And Wellness Weekly Trademarks Review: 16 April
Trademarks are registered and published for opposition with the US Patent and Trademark Office and are published weekly in the agency's Official Gazette.
Beauty Packaging Producers: July Marks Registration Deadline With PRO In Three States
Companies considered producers of single-use packaging in Oregon, Colorado and California must register with Circular Action Alliance, the leading (and currently only) producer responsibility organization, by 1 July 2024 under new state recycling laws.